Sustainability | March 11, 2022
Daiichi Sankyo commits US $1 million humanitarian aid to Ukraine
The money will be donated to the United Nations Children’s Fund (UNICEF)
The money will be donated to the United Nations Children’s Fund (UNICEF)
Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer
First of three Amneal biosimilars expected for U.S. approval and launch in 2022
Company has bought 7.73 million shares for KRW 146.1 billion thus securing the largest shareholder status in Bukwang Pharmaceutical
High level of vaccine efficacy maintained over a 6-month period of surveillance
Innovative TIMScore for dda-PASEF and dia-PASEF libraries, combined with TIMS DIA-NN identifies 9000 protein groups from 200 ng K562 lysate in just 35 min gradient
UNICOR-v has the potential to protect against future epidemics caused by a coronavirus jumping from animals to humans, but also against new variants emerging from SARS-Cov-2
Therapeutic use of the product is for short term symptomatic relief of colds, chills and influenza including chesty coughs
Phase 2a clinical proof-of-concept biomarker study for PXL065 in ALD now anticipated to start midyear
The partnership is already underway having launched earlier last week, and the contract could be worth up to £211 million.
Subscribe To Our Newsletter & Stay Updated
